Feature|Videos|April 30, 2024

Lonza's Commitment to the Future

Author(s)Lonza

Meeta B. Kratz (Global Vice President, Product Management & Marketing, Lonza Capsule and Health Ingredients) talks about Lonza's future and how that works in tandem to meet client needs.

Meeta B. Kratz sat down with Pharmaceutical Technology to highlight how Lonza is looking ahead. Learn more about:

  • How Lonza is optimizing their network to meet the evolving needs of customers while minimizing environmental impact.
  • The strive to push the boundaries and develop new solutions that address the evolving needs of the industry.
  • The commitment to providing customers with consistent supply, exceptional quality, and unparalleled service, no matter the challenge.

Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.
Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.